Tudor Investment Corporation »

Cabaletta Bio shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $404k 150k 2.69
2024-12-31 $47k 21k 2.27
2024-03-31 $364k 21k 17.06

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
State Street SPDR S&P 500 ETF Trust - US ETP ETF Option Call Option (SPY)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)
Nvidia Corp - US Equity (NVDA)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Microsoft Corp - US Equity (MSFT)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
Tesla Inc - US Equity (TSLA)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Meta Platforms Inc - US Equity (META)
Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)
Alibaba Group Holding Ltd - US Depository Receipt (BABA)
Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Cabaletta Bio

T. Rowe Price Investment Management
Bain Capital Life Sciences Investors
Jennison Associates
Adage Capital Partners GP
Millennium Management
Cormorant Asset Management
Vanguard Group
Vanguard Capital Management
Two Sigma Investments
BlackRock
Superstring Capital Management
Renaissance Technologies
Morgan Stanley
Opaleye Management
Woodline Partners

View all funds holding Cabaletta Bio